GlaxoSmithKline: The World's Biggest Biotech Startup?
GlaxoSmithKline's discovery performance units make the company resemble a collection of biotech start-ups rather than a big pharma giant.
Fed's Stimulus Taper Sparks Huge Dow Rally
Merck and other big names soaring following the Fed's afternoon taper announcement.
Synta Pharmaceuticals: 4 Key Investing Takeaways From 2013
Let’s take a look at 4 key investing takeaways from Synta’s volatile year, and how larger companies, like Infinity Pharmaceuticals, Roche, and GlaxoSmithKline, fit into the company’s growth prospects for 2014.